It is unclear what will happen to ProKidney's plans for a $458-million, 330-job commercial manufacturing facility in ...

Headquartered in Winston-Salem, ProKidney leases an undetermined amount of space at the general-industrial-zoned building at ...

The ProKidney management team will also host one-on-one meetings during these events. Interested investors should contact their Guggenheim and Jefferies representatives to schedule meetings.

The live webcast for the Evercore fireside chat will be accessible through the“Events” section of the Investor Relations tab within ProKidney's website at . Investors interested in one-on-one ...

The live webcast for the Evercore fireside chat will be accessible through the “Events” section of the Investor Relations tab within ProKidney’s website at www.prokidney.com. Investors interested in ...

ProKidney WINSTON-SALEM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a late clinical-stage biotech company focused on the development of a first-in ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our ...

ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney's lead product candidate, rilparencel ...

ProKidney's stock has seen major swings due to trial results of their lead molecule, rilparencel, but is now back to its previous levels. The company has a complex history with significant ...

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease ...

The live webcasts will also be accessible through the “Events” section of the Investor Relations tab within ProKidney’s website at www.prokidney.com. Following the completion of each event ...